Time delays and risk factors in the management of patients with active pulmonary tuberculosis: nationwide cohort study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
05 07 2022
05 07 2022
Historique:
received:
09
03
2022
accepted:
21
06
2022
entrez:
5
7
2022
pubmed:
6
7
2022
medline:
8
7
2022
Statut:
epublish
Résumé
Estimating the time delay and identifying associated factors is essential for effective tuberculosis control. We systemically analysed data obtained from the Korea Tuberculosis Cohort in 2019 by classifying delays as presentation and healthcare delays of pulmonary tuberculosis (PTB). Of 6593 patients with active PTB, presentation and healthcare delays were recorded in 4151 and 5571 patients, respectively. The median presentation delay was 16.0 (5.0-40.0) days. Multivariable logistic regression analysis showed that longer presentation delays were associated with neuropsychiatric disease [adjusted odds ratio (OR) 2.098; 95% confidence interval (CI) 1.639-2.687; p < 0.001] and heavy alcohol intake (adjusted OR 1.505; 95% CI 1.187-1.907; p < 0.001). The median healthcare delay was 5.0 (1.0-14.0) days. A longer healthcare delay was associated with malignancy (adjusted OR 1.351; 95% CI 1.069-1.709; p = 0.012), autoimmune disease (adjusted OR 2.445; 95% CI 1.295-4.617; p = 0.006), and low bacterial burden manifested as an acid-fast bacillus smear-negative and tuberculosis polymerase chain reaction-negative status (adjusted OR 1.316; 95% CI 1.104-1.569; p = 0.002). Active case-finding programmes need to focus on patients with heavy alcoholism or neuropsychiatric diseases. To ensure early PTB detection, healthcare providers must carefully monitor patients with malignancy, autoimmune disease, or a high index of suspicion for PTB.
Identifiants
pubmed: 35790866
doi: 10.1038/s41598-022-15264-w
pii: 10.1038/s41598-022-15264-w
pmc: PMC9255533
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
11355Informations de copyright
© 2022. The Author(s).
Références
BMC Public Health. 2019 Nov 14;19(1):1527
pubmed: 31727034
Tuberc Respir Dis (Seoul). 2020 Jul;83(3):218-227
pubmed: 32610836
Lancet Infect Dis. 2021 Aug;21(8):1175-1183
pubmed: 33770534
ERJ Open Res. 2020 Mar 16;6(1):
pubmed: 32201693
Eur Respir J. 2015 Aug;46(2):564-7
pubmed: 25882811
Emerg Health Threats J. 2014 Aug 26;7:24909
pubmed: 25163673
Int J Tuberc Lung Dis. 2014 Mar;18(3):255-266
pubmed: 24670558
Eur Respir J. 2015 Apr;45(4):928-52
pubmed: 25792630
BMC Pulm Med. 2019 Nov 6;19(1):201
pubmed: 31694601
Sci Rep. 2021 Jan 18;11(1):1694
pubmed: 33462255
Clin Microbiol Infect. 2020 Aug;26(8):1058-1062
pubmed: 32035233
South Asian J Cancer. 2012 Jul;1(1):36-42
pubmed: 24455507
Lancet Reg Health West Pac. 2020 Nov 28;5:100059
pubmed: 34327397
Jundishapur J Microbiol. 2015 Mar 21;8(3):e19238
pubmed: 25861434
Int J Tuberc Lung Dis. 2006 Jan;10(1):24-30
pubmed: 16466033
Lancet. 2015 May 2;385(9979):1799-1801
pubmed: 25814376
J Clin Tuberc Other Mycobact Dis. 2018 Apr 11;11:28-36
pubmed: 31720389
BMC Infect Dis. 2019 May 31;19(1):489
pubmed: 31151423
Ann Palliat Med. 2021 Mar;10(3):2948-2957
pubmed: 33691443
BMC Pulm Med. 2017 Dec 13;17(1):202
pubmed: 29237451
Int J Infect Dis. 2018 Nov;76:6-13
pubmed: 30030177
Int J Tuberc Lung Dis. 1999 Dec;3(12):1088-95
pubmed: 10599012
Sci Rep. 2019 Mar 19;9(1):4849
pubmed: 30890727
BMC Infect Dis. 2005 Dec 12;5:112
pubmed: 16343350
PLoS One. 2013 Oct 29;8(10):e77456
pubmed: 24204834
Am J Epidemiol. 1989 Jan;129(1):125-37
pubmed: 2910056
BMJ Open. 2014 Jun 10;4(6):e004818
pubmed: 24916087
ERJ Open Res. 2019 Nov 04;5(4):
pubmed: 31720296
Swiss Med Wkly. 2018 Sep 06;148:w14659
pubmed: 30232794